Document Detail


Time-dependent changes in cardiac growth after kidney transplantation: the impact of pre-dialysis ventricular mass.
MedLine Citation:
PMID:  17510095     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Left ventricular hypertrophy (LVH) is common in chronic kidney disease (CKD), including kidney transplant recipients. However, time-related left ventricular mass changes (DeltaLVM) from pre-dialysis stage to beyond the first post-transplant year have not been clearly identified. METHODS: We studied a cohort of 60 stages 4-5 CKD patients without overt cardiac disease, who underwent three echocardiograms during follow-up: at pre-dialysis stage, on dialysis and after kidney transplantation (KT). Multiple linear regression was used to model DeltaLVM from baseline study. Cox proportional analysis was used to determine risk factors associated with either de novo LVH or>20% DeltaLVMI over time. RESULTS: Patients with baseline LVH (n=37; 61%) had a higher body mass index (BMI) than those without LVH (n=23; 39%) (P=0.013). BMI, haemoglobin levels (P=0.047) and non-use of angiotensin-converting enzyme inhibitors (ACEI) (P=0.057) were associated with baseline left ventricular mass index (LVMI). Twelve out of 23 patients (52%) with normal LVM at baseline, developed either de novo LVH or>20% DeltaLVMI at follow-up. On the other hand, 29 (78%) of those with initial LVH maintained this abnormality, and 8 (22%) normalized LVM post-transplantation. Factors associated with DeltaLVMI were age (P=0.01), pre-dialysis LVMI (P<0.0001), serum creatinine (P=0.012) and the use of ACEI post-transplantation (P=0.009). In Cox analysis, pre-dialysis LVMI was associated with de novo LVH or>20% DeltaLVMI over time (hazard ratio 1.009; 95% confidence interval 1.004 to 1.015; P=0.001). CONCLUSIONS: Successful KT may not completely normalize LVM post-transplantation. Pre-dialysis LVMI, traditional risk factors and no use of ACEI may perpetuate cardiac growth following KT.
Authors:
Domingo Hernández; Ana González; Margarita Rufino; Ignacio Laynez; Alejandro de la Rosa; Esteban Porrini; Juan Lacalzada; Antonio Barragán; Víctor Lorenzo; Armando Torres
Related Documents :
12198215 - Effects of haemodialysis on maximum p wave duration and p wave dispersion.
12197925 - End-stage renal disease and its treatment in venezuela.
18799605 - Psychometric evaluation of the national kidney dialysis and kidney transplantation stud...
8821835 - Patients' views in the choice of renal transplant.
1173185 - Anicteric carbenicillin hepatitis. eight episodes in four patients.
8384335 - Increased prevalence of dialysis-dependent renal failure in ethnic minorities in the we...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2007-05-17
Journal Detail:
Title:  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association     Volume:  22     ISSN:  0931-0509     ISO Abbreviation:  Nephrol. Dial. Transplant.     Publication Date:  2007 Sep 
Date Detail:
Created Date:  2007-08-28     Completed Date:  2007-11-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8706402     Medline TA:  Nephrol Dial Transplant     Country:  England    
Other Details:
Languages:  eng     Pagination:  2678-85     Citation Subset:  IM    
Affiliation:
Department of Nephrology, Hospital Universitario de Canarias, E-38320, La Laguna, Tenerife, Spain. dhmarrero@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Demography
Echocardiography
Female
Follow-Up Studies
Heart / growth & development*
Heart Ventricles / growth & development*
Humans
Kidney Transplantation*
Male
Middle Aged
Organ Size
Regression Analysis
Renal Dialysis*
Time Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism.
Next Document:  The long-term outcome of 93 patients with proliferative lupus nephritis.